Breakthrough as new drug promises to shield child cancer patients from hearing loss

A new study, which is to be presented to the RNID Hearing Therapeutics Summit, found that a drug called Pedmark, also known as Pedmarqsi, lowers the risk of hearing loss brought on by cisplatin chemotherapy.

Read more: https://www.independent.co.uk/news/health/child-cancer-patients-uk-rnid-hearing-loss-b2402304.html